English
中文
HOME
ABOUT US
COMPANY PROFILE
ENTERPRISE VISION
JOIN US
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
MOST RECOMMENDED
QUALITY & COMPLIANCE
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
CONTACT US
Home >
NEWS
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
The European Commission has approved Pfizer’s Xeljanz as a treatment for psoriatic arthritis (PsA), significantly expanding the drug’s scope.
European regulators are allowing use of Xeljanz (tofacitinib citrate) 5mg twice daily in combination with methotrexate for to treat active PsA in adults who have had an inadequate response or who have been intolerant to a prior disease-modifying anti-rheumatic..
2018-08-06
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection~The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients..
2017-03-11
New US nod for Merck's nausea and vomiting drug
US regulators have approved a single-dose version of Merck & Co's chemotherapy-associated nausea and vomiting drug Emend.The jab's use has been cleared, in combination with other anti-emetics, for the prevention of delayed nausea and vomiting in ad..
2016-08-24
First
Previous
current 6/6 page
total 33 records
per page 6 Article
4
5
6
Next
End
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel:
+86-0755-8670 3119
QQ: 530953397 Email:
info@senovatech.com